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Late Outcomes of Ventricular Septal Defect Surgery*Daphne T. Hsu, MDS ince the publication by Lillehei et al. of theseminal report of successful ventricular septaldefect closure 60 years ago (1), dramatic im-
provements in surgical mortality and short- to
medium-term outcomes have occurred (2–4). As a
result of these improvements, mortality in infants
and children with a ventricular septal defect has
fallen 60% to 80% since 1979, and the prevalence of
adults with the diagnosis of a ventricular septal defect
is increasing (5,6). With a greater number of adults
surviving decades after successful congenital heart
surgery, the urgency for better characterization of
the congenital heart disease–related morbidities and
mortality that occur late after surgical intervention
is growing. The report by Menting et al. (7)
in this issue of the Journal adds important informa-
tion to the limited data available regarding out-
comes in late survivors of ventricular septal defect
closure (8–11).SEE PAGE 1941The existing reports of outcomes in long-term
survivors of ventricular septal defect closure span
several eras of open heart surgery. The results of
30 and 53 years of follow-up of Lillehei’s index
cohort of patients who underwent closure between
1954 and 1955 using extracorporeal cross-circulation
were published in 1986 and 2009, respectively (8,9).
Because of the limitations in the size of the children
for whom cross-circulation could be used effectively
as a means of extracorporeal support, nearly one-half
of the original cohort were operated on at age 1 year*Editorials published in the Journal of the American College of Cardiology
reﬂect the views of the authors and do not necessarily represent the
views of JACC or the American College of Cardiology.
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operative period was 10% over a 30-year period,
with only 1 additional death occurring between
30 and 53 years after closure. In 1988, the Second
Natural History Study reported on the outcomes of
children with a ventricular septal defect operated on
between 1958 and 1969 (11). Despite a decade of im-
provements in surgical techniques and myocardial
preservation, 25-year mortality in survivors of the
early post-operative period was 11%, similar to the
cohort reported by Lillehei et al. In the current report,
closure was performed even more recently (1968 to
1980); however, the mortality among survivors of the
early post-operative period was surprisingly similar
to the earlier reports (13% at 20 years) (7). Improve-
ments in peri-operative surgical mortality do not
appear to have translated into improvements in late
mortality.
The current report highlights several areas that the
cardiovascular specialist caring for adult survivors of
ventricular septal defect closure must monitor care-
fully. Most important, arrhythmias and heart failure
have a signiﬁcant negative impact on late outcomes
in patients who have undergone ventricular septal
defect closure. Sudden death is an important mode
of death in this population, and the identiﬁcation
and validation of a risk proﬁle for tachyarrhythmias
has the potential to identify patients who would
beneﬁt from primary or secondary prophylaxis
with an internal cardioverter-deﬁbrillator or medical
therapy.
The progressive deterioration of biventricular car-
diac function that was reported in the current cohort
raises concerns that a signiﬁcant proportion of
these patients are at risk to develop heart failure in
the decades to come. The ability of neurohormonal
blockade to reverse the ventricular remodeling and
prevent clinical heart failure is unknown in this
population. There may be underlying differences in
the myocardium of the patient who has undergone
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1953ventricular septal defect closure that are not compa-
rable to that of an adult heart with an ischemic
or primary cardiomyopathy. The differences may af-
fect the response to angiotensin-converting enzyme
inhibition or beta-blockade. Use of beta-blockade in a
patient with arrhythmias may also present challenges
that require careful balancing of the risks and beneﬁts
before initiation and during therapy.
Once the patient was beyond the early post-
operative period, late cardiac interventions in the
current cohort were skewed toward treatment of left-
sided heart lesions. Aortic insufﬁciency detected by
echocardiography also appears to be progressive. It is
difﬁcult to ascertain from the data provided how
many of the patients who developed left-sided le-
sions had left-sided disease apparent at the time of
diagnosis and surgery. Nonetheless, the need for pa-
tients to have regular follow-up to monitor for asso-
ciated lesions is clear.
The quality-of-life assessments and objective ex-
ercise testing results conﬁrm the impressions of pa-
tients and cardiologists alike. Reported quality of life
among the survivors in the current cohort was
excellent and superior to the general population.
Exercise performance was somewhat lower than ex-
pected for the general population but not enough to
impact daily living. The observed deterioration in
exercise capacity over time raises the possibility thatexercise training and increased emphasis on ﬁtness
may be able to arrest or reverse this decline.
The current European Society of Cardiology
recommendation for routine follow-up of a patient
with no signiﬁcant complications after ventricular
septal defect closure is every 5 years (12). The Ameri-
can College of Cardiology/American Heart Associa-
tion guidelines do not recommend follow-up at an
adult congenital heart disease center for the patient
with no residual ventricular septal defect, pulmonary
hypertension, or associated lesions (13). This report
demonstrates ongoing morbidity and mortality in
adults who have undergone ventricular septal defect
closure. The overall population of survivors is still
so small that one would predict the exposure of
a general cardiologist to a patient who has undergone a
ventricular septal defect closure would be limited to a
few patients. Until better risk-stratifying factors are
identiﬁed, a strong argument could be made that even
relatively straightforward patients such as those who
have undergone ventricular septal defect closure
should be followed up at an adult congenital heart
disease center to ensure comprehensive evaluation
and treatment as they age.
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